Treatment of Intraocular Retinoblastoma

  • M. W. WilsonEmail author
Part of the Pediatric Oncology book series (PEDIATRICO)


The extent of intraocular involvement, visual potential of the eye, tumor size, and status of the fellow eye are the principal considerations in devising a treatment strategy for patients with intraocular retinoblastoma. Preservation of life, the eye, and vision are what we hope to achieve. The potential risk of any treatment must be weighed against the possible benefit. The more advanced the disease, the greater the risk to the patient if there is to be any preservation of vision.


Retinal Pigment Epithelium External Beam Radiotherapy Vitreous Cavity Focal Therapy Bilateral Retinoblastoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Abramson DH, Frank CM (1998) Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 105:573-579PubMedCrossRefGoogle Scholar
  2. Abramson DH, Frank CM, Chantada GL et al (1999a) Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastoma. Ophthalmic Genet 20:31-36PubMedCrossRefGoogle Scholar
  3. Abramson DH, Frank CM, Dunkle IJ (1999b) A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology. 106:1947-1950PubMedCrossRefGoogle Scholar
  4. Beck MN, Balmer A, Dessing C et al (2000) First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma. J Clin Oncol 18:2881-2887PubMedGoogle Scholar
  5. Brichard B, Brucycker JJ, DePotter P et al (2002) Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Med Pediatr Oncol 38:411-415PubMedCrossRefGoogle Scholar
  6. Carcaboso AM, Bramuglia GF, Chantada GL et al (2007) Topotecan vitreous levels after periocular or intravenous delivery in rabbits: an alternative for retinoblastoma chemotherapy. Invest Ophthalmol Vis Sci 48:3761-3767PubMedCrossRefGoogle Scholar
  7. Chantada GL, Dunkel IJ, Antoneli CB et al (2007) Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma. Pediatr Blood Cancer 49:256-260PubMedCrossRefGoogle Scholar
  8. Chevez-Barrios P, Chintagumpala M, Mieler W et al (2005) Respone of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. J Clin Oncol 23:7927-7935PubMedCrossRefGoogle Scholar
  9. Chong EM, Coffee RE, Chintagumpala M et al (2006) Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med 130:1669-1672PubMedGoogle Scholar
  10. Dunkel IJ, Lee TC, Shi W et al (2007) A phase II clinical trial of carboplatin for intraocular retinoblastoma. Pediatri Blood Cancer 49:643-648CrossRefGoogle Scholar
  11. Ellsworth RM (1969) Practical management of retinoblastoma. Trans Am Ophthalmol Soc 67:464-534Google Scholar
  12. Friedman DL, Himelstein B, Shields CL et al (2000) Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 18:12-17PubMedGoogle Scholar
  13. Gallie BL, Budning A, DeBoer G et al (1996) Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 114:1321-1328PubMedCrossRefGoogle Scholar
  14. Gombos DS, Kelly A, Coen PG et al (2002) Retinoblastoma treated with primary chemotherapy alone: the significance of tumor size, location and age. Br J Ophthalmol 86:80-83PubMedCrossRefGoogle Scholar
  15. Greenwald MJ, Strauss LC (1996) Treatment of intraocular retinoblastoma with carboplatin and etoposide with retinoblastoma. Ophthalmology 103:1989-1997PubMedGoogle Scholar
  16. Hamel P, Heon E, Gallie BL, Budning AS (2000) Focal therapy in the management of retinoblastoma: when to start and when to stop. J AAPOS 4:334-337PubMedCrossRefGoogle Scholar
  17. Journée-de Korver JG, Keunen JEE (2002) Thermotherapy in the management of choroidal melanoma. Prog Retin Eye Res 21(3):303-317PubMedCrossRefGoogle Scholar
  18. Journee-de Korver JG, Oosterhuis JA, Kakebeeke-Kemme HM (1992a) Transpupillary thermotherapy (TTT) by infrared irradiation of choroidal melanoma. Doc Ophthalmol 82:185-191PubMedCrossRefGoogle Scholar
  19. Journee-de Korver JG, Verberg-van der Marel EH, Oosterhuis JA, van Best JA, de Wolff-Rouendaal D (1992b) Tumoricidal effect of hyperthermia by near infrared irradiation on pigmented hamster melanoma. Lasers Light Ophthalmol 4:175-180Google Scholar
  20. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN (1996) Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 114:1339-1343PubMedCrossRefGoogle Scholar
  21. Laurie NA, Donovan SL, Shih CS et al (2006) Inactivation of the p53 pathway in retinoblastoma. Nature 444:61-66PubMedCrossRefGoogle Scholar
  22. Lumbroso L, Doz F, Levy C et al (2003) Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma. J Fr Ophtalmol 26:154-159PubMedGoogle Scholar
  23. Merchant TE, Gould CJ, Wilson MW et al (2004) Epislceral plaque brachytherapy for retinoblastoma. Pediatr Blood Cancer 43:134-139PubMedCrossRefGoogle Scholar
  24. Mulvihill A, Budning A, Jay V et al (2003) Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma. Arch Ophthalmol 121:1120-1124PubMedCrossRefGoogle Scholar
  25. Murphree AL, Villablanca JG, Deegan WF et al (1996) Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 114:1348-1356PubMedCrossRefGoogle Scholar
  26. Oosterhuis JA, Journee-de Korver JG, Kakebeeke-Kemme HM, Bleeker JC (1995) Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 113:315-321PubMedCrossRefGoogle Scholar
  27. Reese A Retinoblastoma. In: Reese A (1963) Tumors of the eye. Harper and Row, pp 85-161Google Scholar
  28. Robertson DM, Buettner H, Bennett SR (1999) Transpupillary thermotherapy as primary treatment for small choroidal melanomas. Arch Ophthalmol 117:1512-1519PubMedCrossRefGoogle Scholar
  29. Rodriguez-Galindo C, Wilson MW, Haik BG et al (2003) Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol. 21:2019-2025PubMedCrossRefGoogle Scholar
  30. Rodriguez-Galindo C, Chantada GL, Haik BG, Wilson MW (2007) Treatment of retinoblastoma: current status and future directions. Curr Treat Options Neurol 9:294-307PubMedCrossRefGoogle Scholar
  31. Schueler AO, Jurklies C, Heimann H et al (2003) Thermo­chemotherapy in retinoblastoma. Br J Ophthalmol 87:90-95PubMedCrossRefGoogle Scholar
  32. Shields JA, Parsons H, Shields CL et al (1989) The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol 108:260-264PubMedGoogle Scholar
  33. Shields JA, Shields CL, Parsons H et al (1990) The role of photocoagulation in the management of retinoblastoma. Arch Ophthalmol 108:205-208PubMedCrossRefGoogle Scholar
  34. Shields CL, Shields JA, Baez KA et al (1993) Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol 77:544-548PubMedCrossRefGoogle Scholar
  35. Shields CL, Shields JA, Baez KA et al (1994) Optic nerve invasion of retinoblastoma: metastatic potential and clinical risk factors. Cancer 73:692-698PubMedCrossRefGoogle Scholar
  36. Shields CL, De Potter P, Himelstein B et al (1996) Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 114:1330-1338PubMedCrossRefGoogle Scholar
  37. Shields CL, Shields JL, Needle M et al (1997) Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 104:2101-2111PubMedGoogle Scholar
  38. Shields CL, Honavar SG, Meadows AT et al (2002a) Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol 120:1653-1658PubMedCrossRefGoogle Scholar
  39. Shields CL, Shields JA, Perez N et al (2002b) Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases. Ophthalmology 109:225-234PubMedCrossRefGoogle Scholar
  40. Shields CL, Honavar SG, Meadows AT et al (2002c) Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy and enucleation. Am J Ophthalmol 133:657-664PubMedCrossRefGoogle Scholar
  41. Shields CL, Honavar SG, Shields JA et al (2002d) Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 120:460-464PubMedCrossRefGoogle Scholar
  42. Shields CL, Mashayekhi A, Sun H et al (2006) Iodine-125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 patients. Ophthalmology 113:2087-2092PubMedCrossRefGoogle Scholar
  43. Tolentino FI, Tablante RT (1972) Cryotherapy of retinoblastoma. Arch Ophthalmol 87:52-55PubMedCrossRefGoogle Scholar
  44. Van Quill KR, Dioguardi PK, Tong CT et al (2005) Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology 112:1151-1158PubMedCrossRefGoogle Scholar
  45. Wilson MW, Rodriguez-Galindo C, Haik BG et al (2001) Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma. Ophthalmology. 108:2106-2115PubMedCrossRefGoogle Scholar
  46. Wilson MW, Haik BG, Rodriguez-Galindo C (2006) Socioeconomic impact of modern multidisciplinary management of retinoblastoma. Pediatrics 118:e331-e336PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of OphthalmologyThe Hamilton Eye Institute University of Tennessee Health Science CenterMemphisUSA
  2. 2.Departments of Surgery and PathologySt. Jude Children’s Research Hospital MemphisMemphisUSA

Personalised recommendations